Results 221 to 230 of about 5,128,983 (251)

Association between morphometric measurements and disease progression in Cavalier King Charles Spaniels with preclinical degenerative mitral valve disease: A retrospective longitudinal study. [PDF]

PLoS One
Ghilardi S, Colombo FM, Bagardi M, Polli M, Cozzi MCS, Brambilla PG.   +5 more
europepmc   +1 more source

The Impact of a Visualized Steerable Sheath on Radiofrequency Catheter Ablation for First‐Time Atrial Fibrillation Ablation: A Prospective, Randomized, Single‐Blind Study

Catheterization and Cardiovascular Interventions, Volume 108, Issue 3, Page 924-934, September 1, 2026.
ABSTRACT Background A 3D electroanatomical mapping (3D‐EAM) visualized steerable sheath was designed to improve catheter placement and reduce radiation exposure during ablation, an established treatment for atrial fibrillation (AF). However, prospective randomized data comparing the procedural and clinical outcomes of visualized and non‐visualized ...
Chun‐Kai Chen, Chih‐Chieh Yu, Min‐Tsun Liao, Hui‐Chun Huang, Yen‐Bin Liu   +4 more
wiley   +1 more source

Dogs with advanced myxomatous mitral valve disease have evidence of gastrointestinal bacterial translocation and systemic inflammation. [PDF]

PLoS One
Jugan MC, Rands GA, Steiner JM, Cernicchiaro N, Tanner MC, Novotny LM.   +5 more
europepmc   +1 more source

A Randomized Controlled Trial Comparing the TruSteer and FXD Double Curve Delivery Systems for Left Atrial Appendage Occlusion With the Watchman FLX Pro Device—The GUIDE‐LAAO Study

Catheterization and Cardiovascular Interventions, Volume 108, Issue 3, Page 899-907, September 1, 2026.
ABSTRACT Background Deflectable delivery systems have been introduced to enhance coaxial alignment and procedural efficacy during left atrial appendage occlusion (LAAO), yet randomized comparisons with conventional fixed‐curve systems are lacking. Aims The GUIDE‐LAAO trial evaluated whether the TruSteer deflectable delivery system is non‐inferior to ...
Philippe Taieb, Marco Frazzetto, Pedro Soares Teixeira, Steven J. Filby   +3 more
wiley   +1 more source

Immune response in dogs with myxomatous mitral valve disease: insights into monocyte and lymphocyte subtypes and natural killer cells. [PDF]

J Vet Intern Med
Cimerman M, Nemec Svete A, Baš A, Hajdinjak M, Bajc M, Petek S, Pohar K, Ihan A, Krapež U, Krt B, Dolinar K, Miš K, Pirkmajer S, Domanjko Petrič A.   +13 more
europepmc   +1 more source

Minimally invasive mitral valve repair: Ten-year outcomes of the "Re-Lock technique" for complex bileaflet mitral valve disease. [PDF]

JTCVS Open
Speziale G, Bonifazi R, Loizzo T, Greco E, Nasso G.   +4 more
europepmc   +1 more source

Comparison of mortality trends in patients with rheumatic mitral valve disease and nonrheumatic mitral valve disease: A retrospective study in US from 1999 to 2020. [PDF]

Int J Cardiol Heart Vasc
Ahmad E, Ahmed S, Ahmed S, Ashraf H, Akram U, Ahmad S, Ullah I, Khanji M, Awad W, Nkomo V, Ricci F, Bates M, Alkhalil M, Ahmed R, Chahal AA.   +14 more
europepmc   +1 more source

Monoplane Simpson's Method Is Reliable for Left Atrial Volume Assessment in Small Dogs with Myxomatous Mitral Valve Disease. [PDF]

Vet Sci
Kim M, Seo M, Park C.
europepmc   +1 more source

Case Report: Emergency mitral valve plasty in an unstable dog with left atrial rupture secondary to myxomatous mitral valve disease. [PDF]

Front Vet Sci
Wada T, Takemura R, Yotsuida H, Ohashi M, Miyashita N, Uezawa O, Mori T.   +6 more
europepmc   +1 more source

Pilot study on the effects of dapagliflozin on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease. [PDF]

Vet Anim Sci
Saengklub N, Kijtawornrat A, Hamlin RL.
europepmc   +1 more source